TABLE 1.
Crude prevalence of Turner syndrome by surveillance program and pregnancy outcome.
Program | Cases |
Female live births | Prevalence per 10,000 live births |
||
---|---|---|---|---|---|
All cases | Live births and stillbirths only | Totala | Live births and stillbirths only | ||
Massachusetts | 256 | 37 | 245,466 | 10.4 (9.2–11.8) | 1.5 (1.1–2.1) |
Utah | 316 | 178 | 459,106 | 6.9 (6.2–7.7) | 3.9 (3.3–4.5) |
California | 181 | 78 | 400,099 | 4.5 (3.9–5.2) | 1.9 (1.6–2.4) |
MACDPb | 138 | 90 | 410,259 | 3.4 (2.8–4.0) | 2.2 (1.8–2.7) |
Arkansas | 65 | 53 | 320,780 | 2.0 (1.6–2.6) | 1.7 (1.3–2.2) |
Texas | 856 | 697 | 3,477,737 | 2.5 (2.3–2.6) | 2.0 (1.8–2.1) |
South Carolina | 60 | 12 | 597,662 | 1.0 (0.8–1.3) | 0.2 (0.1–0.4) |
Total | 1872 | 1145 | 5,911,109 | 3.2 (3.0–3.3) | 1.9 (1.8–2.1) |
Live births, stillbirths (fetal death ≥20 weeks gestation), and other pregnancy losses (elective termination at any gestational age and miscarriage <20 weeks gestation).
Metropolitan Atlanta Congenital Defects Program.